Hamburgisches Forschungsinstitut fuer CED

Hamburg 20251

0 studies enrolling now · 3 studies all time

What they study most

Crohn's Disease, Ulcerative Colitis

Studies at this site

• Study for Participants With Ulcerative Colitis Previously Enrolled in Etrolizumab Phase II/III Studies — Stopped early
• A Six Week Efficacy, Safety and Tolerability Study of V565 in Crohn's Disease — Completed
• A Study of the Efficacy and Safety of Etrolizumab in Participants With Ulcerative Colitis Who Have Been Previously Exposed to Tumor Necrosis Factor (TNF) Inhibitors — Completed